Beruflich Dokumente
Kultur Dokumente
ScienceDirect
ORIGINAL ARTICLE
* Corresponding author. Department of Medicine and Geriatrics, Caritas Medical Centre, 111 Wong Kong Street, Sham Shui Po, Kowloon,
Hong Kong
E-mail address: dorlafay@hotmail.com (W.-H. Kwok).
http://dx.doi.org/10.1016/j.hkjn.2016.04.002
1561-5413/ª 2016 Hong Kong Society of Nephrology. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Outcomes in elderly patients with end-stage renal disease 43
目的: 在全球性的社會經濟發展下;預期壽命得以延長;導致在老年人口中;末期腎病的發生率亦有
所增長。我們在 65 歲的第 5 期慢性腎病年老患者間;比較了腎置換療法 (RRT) 與保守療法所達到
的存活率。同時;我們亦嘗試找出影響這兩組病人存活的因素。
方法: 這是一項單中心的回溯性研究;對象為 65 歲的第 5 期慢性腎病患者。他們是在 2005 年至
2013 年期間;被轉介至腎科團隊接受預設照顧計劃;以協助他們選擇 RRT 或保守療法;追蹤期至
2014 年 12 月 31 日或病人去世為止。我們比較了兩組病人的基線特徵及死亡率數據。
結果: 本研究共納入 558 位病人;其中 126 (22.6%) 人選擇了 RRT;432 (77.4%) 人選擇了保守療法。
RRT 組的存活中位數為 44.6 個月;較保守療法組的 10.0 個月長。然而;在 >85 歲、共病顯著 (mCCI
11)、或不能獨立行動的病人中;RRT 的存活優勢消失。在 RRT 組中;年齡、共病、及行動力是死
亡的預測因子,在保守療法組中;年齡、行動力、及性別是死亡的預測因子。
結論: 年老末期腎病患者可以獲益於 RRT,然而;在 >85 歲的極高齡者、共病顯著者、或不能獨立行
動的病人中;RRT 的存活優勢不復存在。
patient’s renal function reached the suggested range, to Laboratory parameters: serum creatinine, eGFR, so-
assist in decision making regarding RRT or conservative dium, potassium, calcium, phosphate, bicarbonate, al-
management. Detailed information and experience would bumin, and hemoglobin levels
be explained to the patients and their families during the Time for decision after ACP, death by the end of the
ACP interview, and their physical, psychological, and social study, any change of decision before death, and causes
concerns would be addressed and discussed during weekly of death
renal case conference. Patient’s decision would be
confirmed upon next few follow ups, and then the patient Outcomes
would be referred to either predialysis clinic or palliative
care clinic for regular follow up according to patient’s Primary outcome was survival (defined as patient survival
treatment modality. Whatever the choices were, multidis- from the date of ACP to death or end of the study) be-
ciplinary care would be provided by a team of physicians, tween those who opted for RRT versus those who opted for
specialist nurses, social workers, dietitians, occupational conservative treatment. Secondary outcomes included
therapists, and physiotherapists, in order to optimize factors affecting patients’ treatment modality, predicting
medical and sociopsychological management of renal dis- factors affecting survival of each group, and the cause of
ease. Telephone hotline would be provided for symptom death.
control.
In this study, clinical records of all patients aged Statistical analysis
65 years or above with Stage 5 CKD (defined as
eGFR 15 mL/min/1.73 m2 using the Modification of Diet
All statistical analyses were performed using Statistical
in Renal Disease equation)15 who received ACP over an 8-
Package for the Social Science (SPSS; IBM, Hong Kong),
year period (from January 1, 2005 to December 31, 2013)
Version 22. Basic descriptive statistics were computed for
were retrospectively reviewed. The date of study entry
the demographic data. Survival outcomes were measured
was the date of renal ACP. Late referral was defined as
by KaplaneMeier survival analysis. Chi-square test and
patients who received either dialysis or palliative care
Fisher exact test were used for the categorical variables
service within 30 days of ACP. Patients who were referred
and t test and ManneWhitney U test for continuous vari-
out to another hospital after the ACP, those with recovery
ables as appropriate. Cox proportional hazards model
of renal function who became dialysis independent during
[setting confidence interval (CI) for Exp (B) at 95%] for
the study period, or those defaulted follow ups before a
predicting factors of mortality. The results were expressed
decision was made were excluded from the study. Partic-
as percentage (%) or number (n) for categorical variables,
ipants were followed up till death, lost to follow up, or
and means standard deviation or median for continuous
followed up for a minimum of 1 year till the end of the
variables.
study on December 31, 2014. They were categorized into
conservative treatment group (defined as those who opted
for conservative management after ACP and received no Results
dialysis) and renal replacement (RRT) group (defined as
those who made a decision to commence RRT). Their During the study period, a total of 833 patients
baseline characteristics and survival outcomes were (20e101 years old) with Stage 5 CKD (eGFR 15 mL/min/
studied. 1.73 m2) were referred for renal ACP. Five hundred
and sixty patients (67.2%) were aged 65 years. Two
patients defaulted follow ups after the ACP interview,
Data collection before a decision was made. They were excluded from
the study. The remaining 558 patients aged 65e101 years
Data were collected by a retrospective review of comput- (mean standard deviation: 78.4 7.0 years) were fol-
erized records from the Clinical Management System and lowed up till death or till the end of the study. Among these
from written clinical notes. Baseline characteristics of patients, 442 (79.2%) decided for conservative care and 116
participants were recorded during ACP, which are as (20.8%) opted for RRT. None of the patients opted for pre-
follows: emptive renal transplant at that time. The median duration
for patients to make a decision after ACP was 10.0 days
Demographic data: age and sex (range 0e42 days).
Clinical data: etiology of CKD and modified Charlson’s These patients were followed up regularly by our spe-
Comorbidity Index (mCCI)16,17 cialty teams according to their preference of treatment.
Mental state at renal ACP However, 24 (4.3%) patients changed their option for
Functional status (independent walker, assisted walker, treatment by the end of the study. Seventeen patients
and chairbound or bedridden patients) at ACP changed from conservative care to dialysis and seven from
Socioeconomic factors: marital status, education level, dialysis to conservative care. One of the patients aged
place of abode, presence of caregiver, and receiving 77 years had renal transplant in Mainland China after
comprehensive social security allowance 2 months of private HD. Hence, the final number of patients
Modality of dialysis: self-PD, helper PD, hemodialysis in the conservative group and RRT group became 432
(HD) in a private hospital, HD in a government hospital, (77.4%) and 126 (22.6%), respectively. Ninety-seven pa-
and pre-emptive renal transplant tients (77%) of the RRT group received PD and 29 (23%)
Reason for not choosing dialysis received HD. Two patients from the RRT group died before
Outcomes in elderly patients with end-stage renal disease 45
Table 1 Baseline characteristics between the conservative treatment and renal replacement therapy groups.
Baseline characteristics All patients Conservative group Renal replacement group p
(n Z 558)a (n Z 432)a (n Z 126)a
Demographics
Age (y) 78.4 7.0 79.6 6.8 74.2 6.1 <0.001
Male (%) 43.7 41.7 50.8 0.07
Female (%) 56.3 58.3 49.2 0.07
Etiology of CKD
Diabetic nephropathy (%) 57.9 57.9 57.9 0.99
Hypertensive nephropathy (%) 13.1 13.7 11.1 0.46
Glomerulonephritis (%) 2.0 1.4 4.0 0.07
Polycystic kidney (%) 0.7 0.5 1.6 0.22
Others (%) 5.6 4.9 7.9 0.19
Unknown (%) 20.8 21.8 17.5 0.30
Comorbidity
mCCI scores 8.7 2.3 9.0 2.3 7.8 2.3 <0.001
Congestive heart failure (%) 25.3 28.5 14.3 <0.001
Stroke (%) 25.6 29.2 13.5 <0.001
Dementia (%) 10.6 13.2 1.6 0.001
Hyperlipidemia (%) 24.9 21.1 38.1 <0.001
Diabetes mellitus (%) 60.2 60.4 59.5 0.86
Ischemic heart disease (%) 29.0 30.6 23.8 0.14
Peripheral vascular disease (%) 4.8 4.4 6.3 0.37
Chronic pulmonary disease (%) 3.4 4.2 0.8 0.07
Liver disease (%) 5.6 5.3 6.3 0.66
Cancer (%) 10.8 11.3 8.7 0.41
Hypertension (%) 87.6 88.0 86.5 0.66
Mobility
Independent walker (%) 43.7 37.5 65.1 <0.001
Assisted walker (%) 37.3 39.8 28.6 0.02
Chairbound/bedridden (%) 19.0 22.7 6.3 <0.001
Mental status
Full (%) 78.1 72.9 96.0 <0.001
Limited (%) 14.7 17.8 4.0 <0.001
Incapacitated (%) 7.2 9.3 0.0 <0.001
Socioeconomic factors
Living with relatives (%) 71.3 66.9 86.5 <0.001
Living in nursing home (%) 15.7 17.1 5.6 <0.001
Living alone (%) 12.2 13.7 7.1 0.05
Living in public housing (%) 55.2 58.0 44.5 0.01
Living in self-owned property (%) 21.1 16.8 37.2 <0.001
Living on own income (%) 2.4 1.7 5.3 0.03
Receiving CSSA (%) 31.3 33.8 21.9 0.02
Illiterate (%) 43.9 49.6 22.9 <0.001
Late referral (%) 34.6 32.9 40.2 0.15
Laboratory parameters
eGFR (mL/min/1.73 m2) 10.0 2.9 10.2 2.8 9.3 3.3 0.01
Hemoglobin (g/dL) 8.7 1.5 8.7 1.5 9.0 1.4 0.02
Calcium (mmol/L) 2.07 0.2 2.1 0.2 2.0 0.3 0.84
Phosphate (mmol/L) 1.7 0.5 1.7 0.4 1.8 0.6 0.08
Albumin (g/L) 29.6 6.1 29.6 6.1 29.5 6.0 0.87
CKD Z chronic kidney disease; CSSA Z comprehensive social security allowance; eGFR Z estimated glomerular filtration rate.
Italics is used to highlight those with p < 0.05.
a
Results were expressed as % or mean standard deviation whenever appropriate.
dialysis began. Twenty-two patients from the RRT group Baseline characteristics
received emergency HD before initiating long-term dialysis.
The mean duration from ACP to initiation of RRT was Demographics of the 558 patients are given in Table 1. The
4.2 1.7 months. conservative group was older (mean age 79.6 6.8 years
46 W.-H. Kwok et al.
Table 2 One-year, 2-year, and 5-year survival rates of the conservative and RRT groups.
Overall age 65 y Age 65e74 y Age 75 y
Conservative group RRT group All patients Conservative group RRT group Conservative group RRT group
(n Z 432) (n Z 126) (n Z 558) (n Z 112) (n Z 69) (n Z 320) (n Z 57)
1-y survival 39.6 78.6 48.4 48.2 87.0 36.3 66.7
rate (%)
2-y survival 13.0 54.0 22.2 15.2 65.2 11.9 38.6
rate (%)
5-y survival 0.9 11.9 3.4 1.8 15.9 0.3 5.3
rate (%)
RRT Z renal replacement therapy.
(11.9% vs. 0.9%) survival rates compared with the con- with an mCCI score of 11 in the RRT group. No significant
servative group (Table 2). survival benefit was observed in either low or high comor-
bidity in patients who were chairbound with mCCI scores of
Survival rate in younger and older age groups 8 and >8 (p Z 0.10 and p Z 0.77; Figure 11).
Under subgroup analysis, median survivals of the RRT and In a Cox proportional hazards model, the significant
conservative groups, at age 75 years and 85 years, were predictors of mortality in RRT patients were age [Hazard
32.7 months (95% CI, 21.4e44.0 months) versus 9.1 months ratio (HR) 1.05, 95% CI 1.00e1.10, p Z 0.03), mCCI (HR
(95% CI, 7.2e11.2 months), and 11.7 months (95% CI, 1.12, 95% CI 1.01e1.24, p Z 0.04), and independent
4.4e19.0 months) versus 5.0 months (95% CI, walker (HR 0.17, 95% CI 0.07e0.40, p < 0.001; Table 3).
3.2e6.8 months), respectively. The RRT group had superior This suggested that patients on dialysis who were younger,
1-year and 2-year survival rates compared with the con- with lower comorbidity and independent mobility, were
servative group (Table 2). The superiority was preserved associated with better outcomes compared with those who
even in the older age group, although the differences were were older with high comorbidity and dependent mobility.
smaller. At the age of 75 years, the 1-year and 2-year Applying the same model in the conservatively managed
survival rates of the RRT and conservative groups were patients produced slightly differing results (Table 4). The
66.7% versus 36.3% and 38.6% versus 11.9%, respectively. predictors of mortality were age (HR 1.02, 95% CI
1.00e1.03, p Z 0.04), mobilitydwith better survival in
Factors associated with survival in the RRT and those able who were to walk unaided (HR 0.14, 95% CI
conservative treatment groups 0.07e0.26, p < 0.001) compared with those who were
The survival advantage was preserved in those receiving dependent (HR 0.29, 95% CI 0.15e0.56, p < 0.001), and
RRT with low comorbidity and an mCCI score of 6 sexdfemale patients have a 35% reduced risk compared
(p < 0.001) or with independent mobility (p < 0.001). with male patients (HR 0.65, 95% CI 0.53e0.80, p < 0.001).
However, the survival benefit was lost when the patient’s However, mCCI did not reach statistical significance in the
age was 85 years or more (p Z 0.96), when the patient had conservative group (p Z 0.66). In this study, diabetes
high comorbidity with an mCCI score of 11 (p Z 0.087), or mellitus (p Z 0.58 vs. p Z 0.45) and ischemic heart dis-
in patients with impaired mobility (p Z 0.22; Figures 3e5). ease (p Z 0.39 vs. p Z 0.08) did not have significant
Under subgroup analysis of very old patients, contribution to mortality in both the conservative and the
aged 85 years, low or high mCCI scores did not show any RRT group.
significant difference in their survival (p Z 0.18 and
p Z 0.17) (Figure 6). The survival benefit persisted in pa- Discussion
tients who were able to walk unaided (p Z 0.04), but was
lost in assisted walkers or chairbound patients (p Z 0.96
Older patients with advanced CKD are at higher risks of
and p Z 0.59) (Figure 7). However, only 96 patients were
death, end-stage renal failure, acute coronary syndrome,
aged 85 years, with 89 of them from the conservative
and stroke compared with people of the same age with
group and only seven from the RRT group. The number of
normal or mildly reduced eGFR.18,19 With timely specialist
patients was even smaller when they were divided into
referral and initiation of dialysis, patients with advanced
subgroups. The three independent walkers aged 85 years
CKD may benefit from longer survival, better control of
had a cumulative survival of at least 30 months from ACP,
metabolic and electrolyte imbalance, anemia, and lower
which was longer than we expected.
risks of cardiovascular events. Therefore, elderly patients
The survival advantage was preserved in patients of all
may still benefit from RRT, but there are limited local data
age groups who were independent walkers (all with
showing to how old of age the benefit preserves. In our
p < 0.05; Figure 8), but lost in those who were chairbound
study, a total of 558 patients aged 65 years or older, with
(all with p > 0.1; Figure 9). Similarly, a significant survival
eGFR 15 mL/min/1.73 m2, received ACP for renal treat-
advantage was observed in patients who were independent
ment. Among these patients, 126 (22.6%) opted for RRT and
walkers with an mCCI score of 11 (p < 0.001), but the
432 (77.4%) decided for conservative management. The RRT
advantage was lost in patients with an mCCI score of >11
group had a significant survival advantage compared with
(p Z 0.42; Figure 10). However, there was only one patient
the conservative group. This survival benefit was preserved
48 W.-H. Kwok et al.
Figure 5 Comparison of KaplaneMeier survival curves for Figure 6 Comparison of KaplaneMeier survival curves for
patients in the conservative and RRT groups with independent patients aged 85 years in the conservative and RRT groups
and impaired mobility. ACP Z advance care planning; with low mCCI (6) and high mCCI (9) scores. ACP Z advance
Cum Z cumulative; RRT Z renal replacement therapy. care planning; Cum Z cumulative; mCCI Z modified Charlson’s
Comorbidity Index; RRT Z renal replacement therapy.
Figure 7 Comparison of KaplaneMeier survival curves for patients in the conservative and RRT groups, who were aged 85 years
and with different functional status. ACP Z advance care planning; Cum Z cumulative; RRT Z renal replacement therapy.
which also contribute to the better survival outcomes. compared with 10 months in those who opted for conser-
Hussain et al23 and Smith et al24 had also reported that the vative management. This survival benefit was preserved in
conservative group was older, with higher comorbidity and the older age group of >75 years, but was lost in very old
a poorer performance status (all p < 0.001), compared patients aged 85 years.
with the dialysis group. However, Joly and colleagues25 Compared with previous studies, our RRT patients had
were unable to show the difference in comorbidity be- relatively longer survival probably because of a younger age
tween the two groups; this might be due to the recruit- of 65 years. Under subgroup analysis, the median survival
ment of an older age group of >80 years, which already of both RRT and conservative group patients decreased with
had uniformly high levels of comorbidity. age. At age 75 years, the median survivals were
32.7 months and 9.1 months, respectively, in the RRT and
Survival of RRT and conservative treatment conservative groups. At age 85 years, the median sur-
vivals decreased to 11.7 months and 5.0 months, respec-
In this study, patients who opted for RRT had a significant tively. The 1-year and 2-year survival rates of the RRT group
survival advantage with a median survival of 44 months versus the conservative group at age 65e75 years were
Outcomes in elderly patients with end-stage renal disease 51
Figure 8 KaplaneMeier survival curves for unaided walkers of different ages in the conservative and RRT groups. ACP Z advance
care planning; Cum Z cumulative; RRT Z renal replacement therapy.
87.0% versus 48.2% and 65.2% versus 15.2%, respectively. dialysis, versus 29% and 15% for patients treated conser-
However, the survival rate declined in older age. At age vatively. Sixty percent patients of the dialysis group and
75 years, it was 66.7% versus 36.3% and 38.6% versus 11.9% 88.4% of the conservative group died by the end of the
respectively. Munshi et al26 followed 638 patients on RRT study. These survival outcomes were quite similar to what
for 8 years, in which they reported a similar 1-year survival we identified in our study, but the patients selected in our
rate of 53.5% in those aged 75 years, and the 5-year study had a higher eGFR of 15 mL/min.
survival rate was 2.4%. Withdrawal from dialysis was Apart from very old age of 85 years, in patients with a
the most common cause of death (38%), followed by car- high mCCI score of 11 or poor mobility (who were chair-
diovascular causes (24%) and infections (22%).26 Joly and bound/bedridden), RRT had also lost its survival advan-
colleagues25 followed 101 dialysis and 43 nondialysis pa- tages. However, the survival benefit was preserved even at
tients aged 80 years. Survival was measured from an older age of 85 years for patients with independent
eGFR < 10 mL/min for 12 years. The median survival was mobility, but was lost in all age groups for patients with
28.9 months in the dialysis group and 8.9 months in the poor mobility (i.e. chairbound/bedridden patients). Hus-
conservative group (p < 0.001). The 1-year and 2-year sain et al23 also reported a reduction in the survival
survival rates were 73.6% and 60% in patients treated by advantage in patients older than 80 years, with a high CCI
52 W.-H. Kwok et al.
Figure 9 KaplaneMeier survival curves for chairbound patients of different ages in the conservative and RRT groups.
ACP Z advance care planning; Cum Z cumulative; RRT Z renal replacement therapy.
score >8 and a World Health Organization performance score and independent functional status were more likely
score of 3 or more between dialysis and conservative to have better survival outcomes. However, mCCI did not
groups. This suggested that dialysis might not outweigh predict mortality in the conservative group, but female
conservative management for those with very old age, high patients had a 35% risk reduction in mortality in this group.
comorbidity, and a poor functional status. Chandna and coworkers27 reported similar findings, showing
that mortality increased with age, high comorbidity, and
Factors associated with survival in RRT and diabetes mellitus in both dialysis and conservative groups.
conservative groups They also showed that female patients had a reduced risk
compared with their male counterparts in the conservative
Geriatric patients are more prone to suffering from a va- group. In a Japanese study on PD patients aged 65 years,
riety of functional inconveniences and comorbidities. In it was also demonstrated that a high mCCI score correlated
this study, mCCI, functional status, as well as age were with reduced patient survival and technique survival.
predictors of survival in the RRT group. This suggested that However, this difference was observed only in patients
dialysis patients who were younger, and had a lower mCCI aged 70 years and above, but not in those aged between
Outcomes in elderly patients with end-stage renal disease 53
Figure 10 Comparison of KaplaneMeier survival curves for Figure 11 Comparison of KaplaneMeier survival curves for
independent walkers with different mCCI scores in the con- chairbound patients with different mCCI scores in the conser-
servative and RRT groups. ACP Z advance care planning; vative and RRT groups. ACP Z advance care planning;
Cum Z cumulative; mCCI Z modified Charlson’s Comorbidity Cum Z cumulative; mCCI Z modified Charlson’s Comorbidity
Index; RRT Z renal replacement therapy. Index; RRT Z renal replacement therapy.
65 years and 69 years.28 In two local studies on outcomes of Choosing between RRT and conservative
CAPD patients younger or older than 65 years, there were management
no significant survival differences between the two age
groups, but a poorer survival outcome was reported in In our study, patients aged over 65 years with CKD Stage 5
those who had diabetes mellitus or required assisted CAPD, who opted for RRT had a survival advantage. However, this
which may indicate more dependent functional status.29,30 survival benefit decreased with age, a high mCCI score, and
However, diabetes mellitus and ischemic heart disease did a poor functional status. It is reasonable to consider dialysis
not significantly affect the survival outcomes in both the as an appropriate treatment option for well-informed
RRT and the conservative group in our study. elderly patients with good baseline physical and
54 W.-H. Kwok et al.
number of patients aged above 85 years was relatively 8. Ho YW, Chau KF, Choy BY, Fung KS, Cheng YL, Kwan TH, et al.
small, with only 89 patients in the conservative group and Hong Kong Renal Registry Report 2012. Hong Kong J Nephrol
seven in the RRT group. The number of patients was even 2013;15:28e43.
smaller when they were divided into subgroups according to 9. Yu AW, Chau KF, Ho YW, Li PK. Development of the “peritoneal
dialysis first” model in Hong Kong. Perit Dial Int 2007;27(Suppl
their mobility and mCCI scores. This may make a definite
2):S53e5.
conclusion in this subgroup analysis difficult; we should 10. Li PK, Chow KM. Peritoneal dialysisdfirst policy made suc-
treat this with reservation. Lastly, symptom burden, quality cessful: perspectives and actions. Am J Kidney Dis 2013;62:
of life, and functional outcomes were not assessed in this 993e1005.
study. Future large prospective cohort studies investigating 11. Canaud B, Tong L, Tentori F, Akiba T, Karaboyas A, Gillespie B,
these factors in addition to survival of older people et al. Clinical practices and outcomes in elderly hemodialysis
receiving dialysis versus conservative management are patients: results from the Dialysis Outcomes and Practice
warranted. Patterns Study (DOPPS). CJASN 2011;6:1651e62.
12. Shum CK, Tam KF, Chak WL, Chan TC, Mak YF, Chau KF. Out-
comes in older adults with stage 5 chronic kidney disease:
Conclusion comparison of peritoneal dialysis and conservative manage-
ment. J Gerontol A Biol Sci Med Sci 2014;69:308e14.
Although age affects outcomes of dialysis, old age alone 13. Dasgupta I, Rayner HC. Dialysis versus conservative manage-
is not an absolute contraindication to dialysis. This study ment of elderly patients with advanced chronic kidney disease.
Nat Clin Pract Nephrol 2007;3:480e1.
has contributed to our understanding of the prognosis in
14. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians
older patients with Stage 5 CKD treated by RRT or con-
and nonagenarians starting dialysis in the United States. Ann
servative management. A significant survival benefit Intern Med 2007;146:177e83.
could be observed in older patients receiving dialysis. 15. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified
However, survival advantages of dialysis were lost in pa- glomerular filtration rate estimating equation for Chinese
tients of very advanced age who were older than patients with chronic kidney disease. JASN 2006;17:
85 years, in those with high comorbidity, or in more 2937e44.
functionally dependent patients. In these patients, con- 16. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the
servative management is a reasonable alternative. While Charlson comorbidity index for use in patients with ESRD. Am J
our results contribute to the information that can guide Kidney Dis 2003;42:125e32.
17. Fried L, Bernardini J, Piraino B. Charlson comorbidity index as
patients in making a treatment decision, an individual-
a predictor of outcomes in incident peritoneal dialysis pa-
ized approach to decision making is mandatory, in respect
tients. Am J Kidney Dis 2001;37:337e42.
of individual’s needs and rights. 18. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S,
Quinn RR, et al. Relation between kidney function, protein-
Conflicts of interest uria, and adverse outcomes. JAMA 2010;303:423e9.
19. O’Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S,
Mehta K, et al. Mortality risk stratification in chronic kidney
All contributing authors declare no conflicts of interest. disease: one size for all ages? J Am Soc Nephrol 2006;17:
846e53.
References 20. Carson RC, Juszczak M, Davenport A, Burns A. Is maximum
conservative management an equivalent treatment option to
1. World Health Organization. Good health adds life to years: dialysis for elderly patients with significant comorbid disease?
global brief for World Health Day 2012. Geneva: World Health CJASN 2009;4:1611e9.
Organization; 2012. 21. Verberne WR, Bos WJW. Survival of elderly renal patients
2. Davies DF, Shock NW. Age changes in glomerular filtration rate, choosing either conservative management or renal replace-
effective renal plasma flow, and tubular excretory capacity in ment therapy. Nephrol Dial Transplant 2015;30(Suppl 3):iii47.
adult males. J Clin Invest 1950;29:496e507. 22. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS,
3. Musso CG, Oreopoulos DG. Aging and physiological changes of Harris FE. Dialysis or not? A comparative survival study of pa-
the kidneys including changes in glomerular filtration rate. tients over 75 years with chronic kidney disease stage 5.
Nephron Physiol 2011;119(Suppl 1):1e5. Nephrol Dial Transplant 2007;22:1955e62.
4. U.S. Renal Data System. USRDS 2014 Annual Data Report: 23. Hussain JA, Mooney A, Russon L. Comparison of survival anal-
Epidemiology of Kidney Disease in the United States, National ysis and palliative care involvement in patients aged over 70
Institutes of Health, National Institute of Diabetes and Diges- years choosing conservative management or renal replacement
tive and Kidney Disease, Bethesda, MD, 2014. United States therapy in advanced chronic kidney disease. Palliat Med 2013;
Renal Data System, Web site. Available at: http://www.usrds. 27:829e39.
org/adr.htm, 2014. Published November 2014. [Accessed 9 Jul 24. Smith C, Da Silva-Gane M, Chandna S, Warwicker P,
2015]. Greenwood R, Farrington K. Choosing not to dialyse: evaluation
5. UK Renal Registry Report 2014, Web site. Available at: http:// of planned non-dialytic management in a cohort of patients
www.renalreg.org. 2014. Published December 2014. [Accessed with end-stage renal failure. Nephron Clin Pract 2003;95:
9 Jul 2015]. c40e6.
6. Pippias M, Stel VS, Diez JMA, Afentakis N, Herrero-Calvo JA, 25. Joly D, Anglicheau D, Alberti C, Nguyen AT, Touam M,
Arias M, et al. Renal replacement therapy in Europe: a sum- Grünfeld JP, et al. Octogenarians reaching end-stage renal
mary of the 2012 ERA-EDTA Registry Annual Report. Clin Kidney disease: cohort study of decision-making and clinical out-
J 2015;8:248e61. comes. J Am Soc Nephrol 2003;14:1012e21.
7. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Preva- 26. Munshi SK, Vijayakumar N, Taub NA, Bhullar H, Lo TC,
lence of chronic kidney disease in China: a cross-sectional Warwick G. Outcome of renal replacement therapy in the very
survey. Lancet 2012;379:815e22. elderly. Nephrol Dial Transplant 2001;16:128e33.
56 W.-H. Kwok et al.
27. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, 33. Cohen LM, Moss AH, Weisbord SD, Germain MJ. Renal palliative
Greenwood RN, Farrington K. Survival of elderly patients with care. J Palliat Med 2006;9:977e92.
stage 5 CKD: comparison of conservative management and 34. Tse DM-W. Experience of a renal palliative care program in a
renal replacement therapy. Nephrol Dial Transplant 2011;26: Hong Kong center: characteristics of patients who prefer
1608e14. palliative care to dialysis. Hong Kong J Nephrol 2009;11:50e8.
28. Hiramatsu M. How to improve survival in geriatric peritoneal 35. Kwok AO, Yuen SK, Yong DS, Tse DM. The symptoms preva-
dialysis patients. Perit Dial Int 2007;27(Suppl 2):S185e9. lence, medical interventions, and health care service needs for
29. Li PK, Law MC, Chow KM, Leung CB, Kwan BC, Chung KY, et al. patients with end-stage renal disease in a renal palliative care
Good patient and technique survival in elderly patients on program. Am J Hosp Palliat Care 2015 Aug 9. Pil:
continuous ambulatory peritoneal dialysis. Perit Dial Int 2007; 1049909115598930. (Epub ahead of print).
27(Suppl 2):S196e201. 36. Burns A. Conservative management of end-stage renal failure:
30. Szeto CC, Wong TYH, Leung CB, Wang AYM, Law MC, Lui SF, masterly inactivity or benign neglect? Nephron Clin Pract 2003;
et al. Age itself is not a prognostic indicator of poor outcome in 95:c37e9.
elderly Chinese patients treated with continuous ambulatory 37. Morton RL, Tong A, Howard K, Snelling P, Webster AC. The
peritoneal dialysis (CAPD). Hong Kong J Nephrol 1999;1:23e9. views of patients and carers in treatment decision making for
31. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, chronic kidney disease: systematic review and thematic syn-
Landefeld CS, McCulloch CE. Functional status of elderly adults thesis of qualitative studies. BMJ 2010;340:c112.
before and after initiation of dialysis. N Engl J Med 2009;361: 38. Swidler M. Geriatric renal palliative care is coming of age. Int
1539e47. Urol Nephrol 2010;42:851e5.
32. Lamping DL, Constantinovici N, Roderick P, Normand C, 39. Fassett RG, Robertson IK, Mace R, Youl L, Challenor S, Bull R.
Henderson L, Harris S, et al. Clinical outcomes, quality of life, Palliative care in end-stage kidney disease. Nephrology 2011;
and costs in the North Thames Dialysis Study of elderly people 16:4e12.
on dialysis: a prospective cohort study. Lancet 2000;356:
1543e50.